SCHEMBL21990303

SCHEMBL21990303

NC1(n2ccnn2)C=CNC(=O)N1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9557447 0.63
SCHEMBL7064203 0.60
SCHEMBL2516164 0.59
SCHEMBL30836898 0.57
SCHEMBL30833854 0.54
SCHEMBL24783311 0.54 CYP19A1 (0.37)
SCHEMBL3148920 0.54 NOTUM (0.34)
SCHEMBL15934416 0.53
SCHEMBL18992684 0.52
SCHEMBL23581044 0.51

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11905287-B2 4-substitued cytisine analogues THE UNIVERSITY OF BRISTOL (GB) 2024-02-20 US disclosed
US-20230203038-A1 4-SUBSTITUED CYTISINE ANALOGUES THE UNIVERSITY OF BRISTOL (GB) 2023-06-29 US disclosed
US-11667638-B2 4-substitued cytisine analogues THE UNIVERSITY OF BRISTOL 2023-06-06 US disclosed
EP-4112620-A1 CYTISINE DERIVATIVES FOR THE TREATMENT OF ADDICTION The University of Bristol (GB) 2023-01-04 EP disclosed
US-20200172544-A1 COMPOUNDS THE UNIVERSITY OF BRISTOL (GB) 2020-06-04 US disclosed